Skip to main content

Horizon Therapeutics in 'highly preliminary' talks on possible sale

By Business Wire  
   November 30, 2022

DUBLIN - The Board of Horizon Therapeutics plc confirms that it is engaged in highly preliminary discussions with Amgen Inc., Janssen Global Services, LLC and Sanofi which may or may not lead to an offer being made for the entire share capital of the company.

Full story

Get the latest on healthcare leadership in your inbox.